MedTrace Logo

Group-based or Individual Information About Disease and Treatment Plan

NCT01699672 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2017-01-26

No results posted yet for this study

Summary

The main aim of the current study is to investigate whether the addition of a standardized,group-based educational program to the information provided by health care personnel improves cancer patients' knowledge level about their disease, planned treatment and common side-effects of the treatment.

Secondary aims are to investigate if the addition of the educational program increases the likelihood of completing treatment as planned, reduces level of anxiety, reduces the frequency of serious side effects, increases patient reported health related quality of life, and increases the degree of patient satisfaction with respect to how they have received the information before, during and after treatment.

Conditions

Interventions

OTHER

Group information

The patients will receive two 1.5-2 hour standardized validated group information sessions in addition to regular information from their doctors and nurses.

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Stein Kaasa, MD, Prof. · St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center

  • Ola Berger, MD · St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center

  • Bjørn H Gønberg, MD, PhD · St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center

  • Kari Sand, Cand Philol · PRC, European Palliative Care Research Center

  • Jo Å Lund, MD, PhD · St Olavs Hospital - Trondheim University Hospital and PRC, European Palliative Care Research Center

  • Jon H Loge, MD, Prof. · National Resource Centre for Studies of Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Department of Behavioral Sciences in Medicine, University of Oslo

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01699672 on ClinicalTrials.gov